Prediction of Progression of Non–Muscle-Invasive Bladder Cancer by WHO 1973 and 2004 Grading and by FGFR3 Mutation Status: A Prospective StudyMaximilian Burger, Ellen C. Zwarthoff, Madelon N.M. van der Aa et al.|European Urology|2008Cited by 178
Mammalian target of rapamycin is activated in human gastric cancer and serves as a target for therapy in an experimental modelSven A. Lang, Oliver Stoeltzing, Andreas Gäumann et al.|International Journal of Cancer|2007Cited by 167
High Frequency of FGFR3 Mutations in Adenoid Seborrheic KeratosesChristian Hafner, Thomas Vogt, Hagen Blaszyk et al.|Journal of Investigative Dermatology|2006Cited by 94
FGFR3 Mutations and a Normal CK20 Staining Pattern Define Low-Grade Noninvasive Urothelial Bladder TumoursJohanna M.M. van Oers, Arndt Hartmann, Peter J. Wild et al.|European Urology|2007Cited by 91
Chromosome 9 deletions are more frequent than <i>FGFR3</i> mutations in flat urothelial hyperplasias of the bladderJohanna M.M. van Oers, Arndt Hartmann, C. Adam et al.|International Journal of Cancer|2006Cited by 90